Miromatrix Medical Inc. Common Stock
MIRO
MIRO was delisted on the 12th of December, 2023.
22 hedge funds and large institutions have $15.4M invested in Miromatrix Medical Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
19% more capital invested
Capital invested by funds: $12.9M → $15.4M (+$2.51M)
1.11% more ownership
Funds ownership: 15.75% → 16.86% (+1.1%)
0% more funds holding
Funds holding: 22 → 22 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$829K |
| 2 |
SFP
Sweet Financial Partners
Fairmont,
Minnesota
|
+$539K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$290K |
| 4 |
LWAM
Legacy Wealth Asset Management
Woodbury,
Minnesota
|
+$120K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$111K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
-$321K |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$267K |
| 3 |
GA
Gagnon Advisors
New York
|
-$259K |
| 4 |
GIPM
G2 Investment Partners Management
New York
|
-$175K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$87K |
MIRO Hedge Fund Activity: Q3 2022 in Review
22 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q3 2022, worth a combined $15.4M — up 19% from $12.9M a quarter earlier.
Fund positioning in MIRO was balanced in Q3 2022: 3 funds opened new positions, 3 closed out, 9 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $829K. The largest seller was Gagnon Securities, cutting an estimated $321K.
- 22 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $15.4M of Miromatrix Medical Inc. Common Stock stock for Q3 2022, up 19% quarter-over-quarter.
- 3 funds opened new Miromatrix Medical Inc. Common Stock positions in Q3 2022 and 3 closed out, a net change of 0 holders.
- The largest Miromatrix Medical Inc. Common Stock buyer in Q3 2022 was Vanguard Group, an estimated $829K added.
- The largest Miromatrix Medical Inc. Common Stock seller in Q3 2022 was Gagnon Securities, an estimated $321K sold.
Based on aggregated 13F filings for Q3 2022.